79 related articles for article (PubMed ID: 15943026)
21. Advances in supportive care of myelodysplastic syndromes.
Gordon MS
Semin Hematol; 1999 Oct; 36(4 Suppl 6):21-4. PubMed ID: 10530713
[TBL] [Abstract][Full Text] [Related]
22. [Current approaches of treatment for myelodysplastic syndrome (MDS)].
Lewandowski K; Goździk J; Hansz J
Acta Haematol Pol; 1995; 26(4):333-41. PubMed ID: 8571734
[TBL] [Abstract][Full Text] [Related]
23. Supportive care, growth factors, and new therapies in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Blood Rev; 2008 Mar; 22(2):75-91. PubMed ID: 18068281
[TBL] [Abstract][Full Text] [Related]
24. Supportive care including growth factors in myelodysplastic syndromes.
Gardin C; Fenaux P
Rev Clin Exp Hematol; 2004 Dec; 8(2):E3. PubMed ID: 16027101
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic growth factors for the treatment of inherited cytopenias.
Zeidler C; Welte K
Semin Hematol; 2007 Jul; 44(3):133-7. PubMed ID: 17631177
[TBL] [Abstract][Full Text] [Related]
26. Colony-stimulating factors and cell cycle in the chemotherapy of acute myelogenous leukemia.
Viallard JF; Puntous M; Grosset C; Lacombe F; Reiffers J
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S103-5. PubMed ID: 8177708
[TBL] [Abstract][Full Text] [Related]
27. 5-azacitidine: An alternative treatment of myelodysplastic syndromes in patient with refractory response to hematopoietic growth factor, a case report and review of literatures.
Suwanawiboon B; Sumida KN
Hawaii Med J; 2004 Jan; 63(1):14-6, 25. PubMed ID: 15011897
[TBL] [Abstract][Full Text] [Related]
28. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
29. Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives.
Musto P
Leuk Res; 2004 Apr; 28(4):325-32. PubMed ID: 15109529
[TBL] [Abstract][Full Text] [Related]
30. Approach to anemia associated with myelodysplastic syndromes.
Hellström-Lindberg E
Curr Hematol Rep; 2003 Mar; 2(2):122-9. PubMed ID: 12901143
[TBL] [Abstract][Full Text] [Related]
31. Growth factor priming in therapy of acute myelogenous leukemia.
Becker PS
Curr Hematol Rep; 2004 Nov; 3(6):413-8. PubMed ID: 15496274
[TBL] [Abstract][Full Text] [Related]
32. Revisiting use of growth factors in myelodysplastic syndromes.
Newman K; Maness-Harris L; El-Hemaidi I; Akhtari M
Asian Pac J Cancer Prev; 2012; 13(4):1081-91. PubMed ID: 22799286
[TBL] [Abstract][Full Text] [Related]
33. Treatment of low-risk myelodysplastic syndrome: hematopoietic growth factors erythropoietins and thrombopoietins.
Santini V
Semin Hematol; 2012 Oct; 49(4):295-303. PubMed ID: 23079059
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes.
Golshayan AR; Jin T; Maciejewski J; Fu AZ; Bershadsky B; Kattan MW; Kalaycio ME; Sekeres MA
Br J Haematol; 2007 Apr; 137(2):125-32. PubMed ID: 17391492
[TBL] [Abstract][Full Text] [Related]
35. Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS).
List AF
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S31-5. PubMed ID: 16085015
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of recombinant hematopoietic colony-stimulating factors.
Shepro DS; Sullivan R
Adv Intern Med; 1991; 36():329-62. PubMed ID: 2024585
[No Abstract] [Full Text] [Related]
37. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
38. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Karthaus M
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():13-27. PubMed ID: 9570676
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic growth factors in the treatment of the myelodysplastic syndromes.
Ganser A
Curr Opin Hematol; 1995 May; 2(3):204-9. PubMed ID: 9371996
[TBL] [Abstract][Full Text] [Related]
40. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
